No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Hester Biosciences Limited, founded in 1987 and headquartered in Ahmedabad, India, specializes in the production and commercialization of veterinary vaccines and a comprehensive array of animal health solutions. The company's operations span both domestic and international markets, structured around two primary divisions: Poultry Healthcare and Animal Healthcare. Its extensive range of poultry vaccines targets numerous conditions, including Newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reovirus infections, Marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, and avian encephalomyelitis. For larger animals, Hester Biosciences provides vaccines designed to combat ailments such as Goat Pox, Peste des Petits Ruminants (PPR), Brucellosis, Mastitis, Metritis, various infectious diseases, reproductive disorders, theileriosis, and parasitic infestations. Beyond vaccines, the company's product portfolio encompasses vital feed supplements like toxin binders, trace minerals, enzyme preparations, and bypass fats. It also supplies disinfectants for maintaining farm hygiene and sanitizing equipment, along with water purification solutions. Nutritional support products are offered, including mineral mixtures, fertility boosters, and growth tonics. A significant portion of their offerings consists of herbal preparations, featuring growth promoters, natural alternatives to choline chloride, stress and immunity enhancers, respiratory aids, liver tonics, wound healing agents, uterine and digestive tonics, anti-bloat remedies, ectoparasiticides, and treatments for anti-mastitis and anti-prolapse conditions.
www.hester.inNo one on the platform currently holds HESTERBIO.NS.
No tracked institution reports a position in HESTERBIO.NS as of their last filing.
No one on the platform has traded HESTERBIO.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| HESTERBIO.NSHester Biosciences Limited | $2207.70 | +1.65% | $18.8B | — |
| BAJAJHCARE.BOBajaj Healthcare Ltd | $320.95 | +0.19% | $10.7B | — |
| BAJAJHCARE.NSBajaj Healthcare Ltd | $321.10 | +0.06% | $10.8B | — |
| BLISSGVS.BOBliss GVS Pharma Limited | $679.90 | -0.94% | $72.5B | — |
| BLISSGVS.NSBliss GVS Pharma Limited | $680.50 | -0.65% | $72.2B | — |
| JAGSNPHARM.BOJagsonpal Pharmaceuticals Limited | $228.10 | +1.11% | $15.0B | — |
| JAGSNPHARM.NSJagsonpal Pharmaceuticals Limited | $228.28 | +1.08% | $15.0B | — |
Source: Financial Modeling Prep · peers by sector/industry